146 related articles for article (PubMed ID: 11090912)
1. Parallel bioassay of 39 tachykinins on 11 smooth muscle preparations. Structure and receptor selectivity/affinity relationship.
Severini C; Salvadori S; Guerrini R; Falconieri-Erspamer G; Mignogna G; Erspamer V
Peptides; 2000 Nov; 21(11):1587-95. PubMed ID: 11090912
[TBL] [Abstract][Full Text] [Related]
2. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
Ganjiwale A; Cowsik SM
Mini Rev Med Chem; 2013 Dec; 13(14):2036-46. PubMed ID: 23937231
[TBL] [Abstract][Full Text] [Related]
4. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore and receptor models for neurokinin receptors.
Poulsen A; Bjørnholm B; Gundertofte K; Pogozheva ID; Liljefors T
J Comput Aided Mol Des; 2003 Nov; 17(11):765-83. PubMed ID: 15072436
[TBL] [Abstract][Full Text] [Related]
6. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
7. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
Strigas J; Burcher E
Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
[TBL] [Abstract][Full Text] [Related]
9. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological assessment of spantide II analogues.
Wang ZY; Feng DM; Wang YL; Tung SR; Wong K; Strichartz GR; Folkers K; Håkanson R
Eur J Pharmacol; 1994 Aug; 260(2-3):121-8. PubMed ID: 7527343
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
12. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
[TBL] [Abstract][Full Text] [Related]
13. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
14. Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.
Grady EF; Baluk P; Böhm S; Gamp PD; Wong H; Payan DG; Ansel J; Portbury AL; Furness JB; McDonald DM; Bunnett NW
J Neurosci; 1996 Nov; 16(21):6975-86. PubMed ID: 8824334
[TBL] [Abstract][Full Text] [Related]
15. Identification, localization and receptor characterization of novel mammalian substance P-like peptides.
Kurtz MM; Wang R; Clements MK; Cascieri MA; Austin CP; Cunningham BR; Chicchi GG; Liu Q
Gene; 2002 Aug; 296(1-2):205-12. PubMed ID: 12383518
[TBL] [Abstract][Full Text] [Related]
16. Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina.
Oyamada H; Takatsuji K; Senba E; Mantyh PW; Tohyama M
Brain Res Dev Brain Res; 1999 Oct; 117(1):59-70. PubMed ID: 10536233
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
18. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.
Goldhill J; Angel I
Eur J Pharmacol; 1998 Dec; 363(2-3):161-8. PubMed ID: 9881585
[TBL] [Abstract][Full Text] [Related]
20. The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity.
Tian Y; Wu LH; Oxender DL; Chung FZ
J Biol Chem; 1996 Aug; 271(34):20250-7. PubMed ID: 8702757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
